Sofia, Bulgaria, February 21, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for participation from “Telso” AD, UIC 131176385.  As a result of the accepted tender offer, "Telso" AD is reduced below the threshold from 5% to 1.44% in the capital of "Sopharma" AD.

Sofia, Bulgaria, February 21, 2023 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that today the Company received a notification for participation from “Donev investments holding, UIC 831915121.  As a result of acquired shares following a tender offer made by "Donev Investments Holding" AD to the shareholders of "Sopharma" AD, "Donev Investments Holding" AD increases its direct participation in the capital of the Company to 35.24%, crossing the threshold of 35%.

Sofia, Bulgaria, February 6, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for January 2023 the Company recorded an increase in sales of 33% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 174% increase in export sales.

Sofia, Bulgaria, February 1, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that in order to more accurately present and prevent deviations in the published information concerning the Company's monthly sales data, the Board of Directors of "Sopharma" AD adopted a decision to extend the deadline for the publication of the relevant information until the 20th of the month following the reporting period.